Neuland Laboratories Limited (NEULANDLAB) โ Announcement | 7 August 2026
Neuland Laboratories announced its participation in upcoming investor meetings, including a group session with Emkay Confluence 2026 on August 12, 2026, and potential one-on-one meetings, as part of its ongoing investor engagement strategy.
About Neuland Laboratories Limited (NEULANDLAB)
Healthcare ยท Pharmaceuticals ยท Listed on NSE
๐ก Get AI alerts when NEULANDLAB files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track NEULANDLAB โ Free๐ก Ask AI about this filing
๐ More NEULANDLAB filings
- Announcement โ 25 September 2026Neuland Laboratories has closed its insider trading window effective October 1, 2026, until 48 hours...
- ๐ด Announcement โ 16 September 2026Neuland Laboratories announced its management will attend the Goldman Sachs Global Healthcare CDMO D...
- ๐ด Announcement โ 15 September 2026Neuland Laboratories announced that its first commercial peptide manufacturing module is now operati...
- ๐ด Announcement โ 9 September 2026Neuland Laboratories announced its management will attend three upcoming investor meetings in Septem...
- ๐ก Board Meeting โ 7 September 2026Neuland Laboratories announced on September 7, 2026, that its board approved โน126 crores capital exp...
๐ฅ Also filed on 7 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when NEULANDLAB files new disclosures
Track NEULANDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NEULANDLAB โ FreeFree account ยท 2 AI queries/day